Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W O Bechstein

Showing results (331-340 of 351) with videos related to

Pageof 36
Sort By:
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 12, 1998
[Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors]T J Vogl, W Schwarz, R Hammerstingl, et al.
Metabolism: Clinical and Experimental|March 22, 2000
Evidence for impaired glucose effectiveness in cirrhotic patients after liver transplantationT Konrad, T Steinmüller, P Vicini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2011
Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trialJ M Löhr, S L Haas, W-O Bechstein, et al.
Transplantation Proceedings|December 1, 1996
Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized studyJ M Langrehr, O Guckelberger, N Nüssler, et al.
Clinical Transplantation|August 1, 1998
A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantationJ M Langrehr, M Glanemann, O Guckelberger, et al.
Transplantation Proceedings|November 20, 1997
Liver transplantation in HBsAg+ patients with postoperative immunoprophylaxisJ M Langrehr, O Guckelberger, U Neumann, et al.
Clinical and Experimental Immunology|November 18, 2003
The immunosuppressive drug mycophenolate mofetil impairs the adhesion capacity of gastrointestinal tumour cellsK Leckel, W-D Beecken, D Jonas, et al.
Transplantation Proceedings|June 24, 1998
A randomized trial comparing anti-interleukin-2 receptor antibody and placebo for immunosuppressive therapy after OLTJ M Langrehr, M Glanemann, A Schneller, et al.
Investigative Radiology|November 1, 1996
Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patientT J Vogl, R Hammerstingl, W Schwarz, et al.
Zeitschrift Fur Gastroenterologie|November 24, 2004
[Consensus-recommendations for sirolimus in liver transplantation]M Golling, T Becker, C Broelsch, et al.
Pageof 36

Showing results (331-340 of 351) with videos related to

Sort By:
Pageof 36
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 12, 1998
[Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors]T J Vogl, W Schwarz, R Hammerstingl, et al.
Metabolism: Clinical and Experimental|March 22, 2000
Evidence for impaired glucose effectiveness in cirrhotic patients after liver transplantationT Konrad, T Steinmüller, P Vicini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2011
Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trialJ M Löhr, S L Haas, W-O Bechstein, et al.
Transplantation Proceedings|December 1, 1996
Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized studyJ M Langrehr, O Guckelberger, N Nüssler, et al.
Clinical Transplantation|August 1, 1998
A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantationJ M Langrehr, M Glanemann, O Guckelberger, et al.
Transplantation Proceedings|November 20, 1997
Liver transplantation in HBsAg+ patients with postoperative immunoprophylaxisJ M Langrehr, O Guckelberger, U Neumann, et al.
Clinical and Experimental Immunology|November 18, 2003
The immunosuppressive drug mycophenolate mofetil impairs the adhesion capacity of gastrointestinal tumour cellsK Leckel, W-D Beecken, D Jonas, et al.
Transplantation Proceedings|June 24, 1998
A randomized trial comparing anti-interleukin-2 receptor antibody and placebo for immunosuppressive therapy after OLTJ M Langrehr, M Glanemann, A Schneller, et al.
Investigative Radiology|November 1, 1996
Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patientT J Vogl, R Hammerstingl, W Schwarz, et al.
Zeitschrift Fur Gastroenterologie|November 24, 2004
[Consensus-recommendations for sirolimus in liver transplantation]M Golling, T Becker, C Broelsch, et al.
Pageof 36